CUAICH PHARMA LIMITED


Director	VIS, Peter Willem


Registered Address	11 Loch Na Leoba Road
	Newtonmore
	PH20 1BW


Registered Number	SC416531 (Scotland)

Balance Sheet as at
28 February 2025

	Notes	2025		2024
		£	£	£	£
Fixed assets
Tangible assets	3		16,663		28,950
Investments	4		177,782		177,782
			194,445		206,732
Current assets
Debtors		91,778		13,184
Cash at bank and on hand		93,607		175,347
		185,385		188,531
Creditors amounts falling due within one year	5	(18,943)		(46,358)
Net current assets (liabilities)			166,442		142,173
Total assets less current liabilities			360,887		348,905
Creditors amounts falling due after one year	6		(7,855)		(31,229)
Net assets			353,032		317,676
Capital and reserves
Called up share capital			100		50
Share premium			(39,002)		(38,952)
Profit and loss account			391,934		356,578
Shareholders' funds			353,032		317,676

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 4 November 2025, and are signed on its behalf by:

VIS, Peter Willem
Director
Registered Company No. SC416531

CUAICH PHARMA LIMITED

Notes to the Financial Statements
for the year ended 28 February 2025

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

	Revenue from sale of goods
	Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

Revenue from sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Employee benefits
	Contributions to defined contribution plans are expensed in the period to which they relate.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Tangible fixed assets and depreciation
	Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:


		Straight line (years)
	Plant and machinery	5
	Fixtures and fittings	2
	Vehicles	4
	Office Equipment	3

	Investments
	Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

Investments

Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

2.	Average number of employees


		2025		2024
	Average number of employees during the year	1		1

3.	Tangible fixed assets

	Plant & machinery	Vehicles	Fixtures & fittings	Office Equipment	Total
	£	£	£	£	£
Cost or valuation
At 01 March 24	-	56,035	833	1,083	57,951
Additions	2,404	-	-	-	2,404
At 28 February 25	2,404	56,035	833	1,083	60,355
Depreciation and impairment
At 01 March 24	-	28,017	833	151	29,001
Charge for year	321	14,009	-	361	14,691
At 28 February 25	321	42,026	833	512	43,692
Net book value
At 28 February 25	2,083	14,009	-	571	16,663
At 29 February 24	-	28,018	-	932	28,950

4.	Fixed asset investments

	Investments in groups¹	Loans to groups²	Total
	£	£	£
Cost or valuation
At 01 March 24	57	177,724	177,781
At 28 February 25	57	177,724	177,781
Impairment
At 01 March 24	-	(1)	(1)
At 28 February 25	-	(1)	(1)
Net book value
At 28 February 25	57	177,725	177,782
At 29 February 24	57	177,725	177,782

	Notes
	¹Investments in group undertakings and participating interests ²Loans to group undertakings and participating interests

5.	Creditors: amounts due within one year

	2025	2024
	£	£
Bank borrowings and overdrafts	-	3,885
Taxation and social security	18,943	21,406
Other creditors	-	3,067
Accrued liabilities and deferred income	-	18,000
Total	18,943	46,358


	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

6.	Creditors: amounts due after one year

	2025	2024
	£	£
Other creditors	7,855	31,229
Total	7,855	31,229